Search for Clinical Trial Results

Sponsored By

Mumps - 23 Studies Found

Status Study
Active, not recruiting Study Name: Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants
Condition: Mumps
Date: 2016-02-23
Interventions:
  • Biological: investigational live attenuated mumps vaccine

Not yet recruiting Study Name: Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants
Condition: Epidemic Parotitis,Mumps
Date: 2017-04-17
Interventions:
  • Biological: ≥3.0 lgCCID50/mlbut ＜3.5lgCCID50/ml Live Attenuated
Completed Study Name: A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children
Condition: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants.
Date: 2012-10-22
Interventions:
  • Biological: 3.50±0.25logCCID50/ml

Completed Study Name: Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
Condition:
  • Measles
  • Mumps
  • Rubella
    • Date: 2013-01-21
    Interventions: Biological: MMR Vaccine Administration of MMR Vaccine by Bio-Manguinhos or MMR Vaccine by GlaxoSmithKlin
Completed Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older
Condition:
  • Rubella
  • Mumps
  • Measles
    • Date: 2014-02-06
    Interventions:
    • Biological: Priorix® 1 do
Completed Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age
Condition:
  • Rubella
  • Mumps
  • Measles
    • Date: 2012-06-14
    Interventions:
    • Biological: Priorix® Sing
Completed Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life
Condition:
  • Measles
  • Mumps
  • Rubella
    • Date: 2012-09-06
    Interventions:
    • Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209
Completed Study Name: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
Condition:
  • Mumps
  • Rubella
  • Measles
    • Date: 2013-06-07
    Interventions: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella)
Completed Study Name: A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)
Condition:
  • Measles
  • Mumps
  • Rubella
    • Date: 2004-09-22
    Interventions:
    • Biological: Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vacc
Completed Study Name: Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Condition:
  • Mumps
  • Rubella
  • Measles
    • Date: 2005-08-04
    Interventions: Biological: Measles, Mumps, Rubella and Chickenpox (live vaccine)
Next >>>